Melanotan II (sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH) is a synthetic cyclic analogue of -MSH (-melanocyte-stimulating hormone) developed at the University of Arizona in the 1980s
The body adopts a series of regulatory measures to adapt to this change, such as promoting the synthesis process of carnitine and increasing the activity or expression level of carnitine synthases to increase the production of endogenous carnitine
Juvenile, San Joaquin Marsh, Orange Co., 10-07
The latest product offering is a powerful antioxidant amino acid, as well as a precursor in the body to the critical antioxidant glutathione one of the bodys most important and abundant antioxidant and detoxification agents.* More specifically, N-Acetyl-L-Cysteine supplies readily available L-cysteine, which acts as an antioxidant itself or as a precursor to glutathione
Published Research Data Quantified findings from peer-reviewed studies on PT-141 (Bremelanotide) amino acid residues in the PT-141 cyclic peptide sequence HPLC-verified purity range across published batch testing Published Research Studies on PT-141 (Bremelanotide) 2008 Bremelanotide: an overview of preclinical CNS effects J Sex Med 2003 PT-141: a melanocortin agonist for the treatment of sexual dysfunction Ann N Y Acad Sci Characterization of PT-141's mechanism of action through melanocortin MC3R/MC4R receptor activation in central nervous system pathways
Wanting to feel your best, inside and out